Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 134 (3), 301-4

Focal Hyperhidrosis: Effective Treatment With Intracutaneous Botulinum Toxin

Clinical Trial

Focal Hyperhidrosis: Effective Treatment With Intracutaneous Botulinum Toxin

M Naumann et al. Arch Dermatol.


Objective: To evaluate the effect of intracutaneous injections of botulinum toxin type A on excessive focal hyperhidrosis.

Design: Therapeutic before-and-after trial over 4 months.

Setting: Neurological and dermatological university departments.

Patients: Eleven patients with excessive axillary, palmar, or plantar hyperhidrosis fulfilling the following criteria: (1) local and systemic drug therapy had failed to improve their symptoms; (2) the patients were severely disabled with respect to their occupation and social activities; and (3) a successful treatment by botulinum toxin would obviate the need for destructive surgical procedures.

Interventions: Three mouse units of botulinum toxin (Botox) per 4-cm2 skin area was injected intracutaneously in 16 axillae, 8 palms, and 2 soles.

Main outcome measures: Reduction of hyperhidrosis as documented by the Minor iodine-starch test and gravimetrical assessment of local spontaneous sweat production measured over 1 minute.

Results: In all patients, botulinum toxin completely abolished sweating in the injected areas (P<.001) within 3 to 7 days. No relevant adverse effects occurred and no clinical recurrence of hyperhidrosis was observed within the follow-up period of up to 5 months. Occasionally, subclinical reactivation of sweat gland function was observed 4 months after treatment.

Conclusions: Intracutaneous botulinum toxin seems preferable to any hitherto used conservative or surgical procedures and may become the therapy of choice in pathological focal hyperhidrosis.

Comment in

Similar articles

See all similar articles

Cited by 9 PubMed Central articles

See all "Cited by" articles

Publication types


LinkOut - more resources